Welcome to the neighborhood: epithelial cell‐derived cytokines license innate and adaptive immune responses at mucosal sites
Top Cited Papers
- 30 October 2008
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 226 (1), 172-190
- https://doi.org/10.1111/j.1600-065x.2008.00713.x
Abstract
Summary: There is compelling evidence that epithelial cells (ECs) at mucosal surfaces, beyond their role in creating a physical barrier, are integral components of innate and adaptive immunity. The capacity of these cells to license the functions of specific immune cell populations in the airway and gastrointestinal tract offers the prospect of novel therapeutic strategies to target multiple inflammatory diseases in which barrier immunity is dysregulated. In this review, we discuss the critical functions of EC‐derived thymic stromal lymphopoietin (TSLP), interleukin‐25 (IL‐25), and IL‐33 in the development and regulation of T‐helper 2 (Th2) cytokine‐dependent immune responses. We first highlight recent data that have provided new insights into the factors that control expression of this triad of cytokines and their receptors. In addition, we review their proinflammatory and immunoregulatory functions in models of mucosal infection and inflammation. Lastly, we discuss new findings indicating that despite their diverse structural features and differential expression of their receptors, TSLP, IL‐25, and IL‐33 cross‐regulate one another and share overlapping properties that influence Th2 cytokine‐dependent responses at mucosal sites.Keywords
This publication has 131 references indexed in Scilit:
- TSLP acts on infiltrating effector T cells to drive allergic skin inflammationProceedings of the National Academy of Sciences of the United States of America, 2008
- IL-33 exacerbates antigen-induced arthritis by activating mast cellsProceedings of the National Academy of Sciences of the United States of America, 2008
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsJournal of Allergy and Clinical Immunology, 2008
- Interleukin 25 promotes the initiation of proallergic type 2 responsesThe Journal of Experimental Medicine, 2007
- Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFκBProceedings of the National Academy of Sciences of the United States of America, 2007
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences of the United States of America, 2007
- Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitisProceedings of the National Academy of Sciences of the United States of America, 2006
- Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsionThe Journal of Experimental Medicine, 2006
- Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tractThe Journal of Experimental Medicine, 2006
- Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLPNature Immunology, 2002